CYTH Logo

Cyclo Therapeutics, Inc. (CYTH) 

NASDAQ
Market Cap
$34.91M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
69 of 809
Rank in Industry
2 of 53

Largest Insider Buys in Sector

CYTH Stock Price History Chart

CYTH Stock Performance

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

Insider Activity of Cyclo Therapeutics, Inc.

Over the last 12 months, insiders at Cyclo Therapeutics, Inc. have bought $5M and sold $0 worth of Cyclo Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Cyclo Therapeutics, Inc. have bought $1.72M and sold $522,370 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Rafael Holdings, Inc. (10 percent owner) — $5M.

The last purchase of 4,000,000 shares for transaction amount of $5M was made by Rafael Holdings, Inc. (10 percent owner) on 2023‑08‑01.

List of Insider Buy and Sell Transactions, Cyclo Therapeutics, Inc.

2023-08-01PurchaseRafael Holdings, Inc.10 percent owner
4M
23.6663%
$1.25$5M-1.38%
2023-04-20PurchaseFINE N SCOTTChief Executive Officer
299,402
2.7233%
$0.71$212,575+105.99%
2023-04-20PurchaseOstronic Francis Patrickdirector
59,881
0.5447%
$0.71$42,516+105.99%
2023-04-20PurchaseSieger Markusdirector
59,881
0.5447%
$0.71$42,516+105.99%
2023-04-20PurchaseTATE JEFFREYChief Operating Officer
29,941
0.2723%
$0.71$21,258+105.99%
2022-09-21PurchaseOstronic Francis Patrickdirector
5,000
0.0594%
$1.76$8,800-14.29%
2022-05-20PurchaseOstronic Francis Patrick
12
0.0001%
$2.00$24-8.59%
2022-05-16PurchaseTATE JEFFREYChief Operating Officer
3,000
0.0357%
$2.12$6,354-12.80%
2022-04-28PurchaseTATE JEFFREYChief Operating Officer
635
0.007%
$2.50$1,588-30.00%
2022-03-29PurchaseSieger Markus
10,000
0.1167%
$2.73$27,300-29.50%
2022-02-07PurchaseFINE N SCOTTChief Executive Officer
10,334
0.1229%
$3.58$36,996-41.90%
2022-01-24PurchaseOstronic Francis Patrickdirector
2,000
0.0246%
$3.75$7,500-41.71%
2022-01-19PurchaseFINE N SCOTTChief Executive Officer
5,000
0.0572%
$3.89$19,450-47.28%
2022-01-19PurchaseOstronic Francis Patrickdirector
1,132
0.0133%
$4.00$4,528-47.28%
2022-01-14PurchaseOstronic Francis Patrickdirector
3,868
0.0434%
$4.00$15,472-49.76%
2021-12-15PurchaseFINE N SCOTTChief Executive Officer
5,000
0.0758%
$3.89$19,450-45.04%
2021-12-15PurchaseOstronic Francis Patrickdirector
3,000
0.0456%
$3.90$11,700-45.04%
2021-12-10PurchaseOstronic Francis Patrickdirector
5,000
0.0792%
$4.40$22,000-48.85%
2021-12-03PurchaseOstronic Francis Patrickdirector
864
0.0135%
$4.75$4,104-52.83%
2021-12-02PurchaseFINE N SCOTTChief Executive Officer
5,000
0.0775%
$4.93$24,650-54.81%

Insider Historical Profitability

<0.0001%
Rafael Holdings, Inc.10 percent owner
6514970
28.6142%
$1.2210
NOVIT, L.P.10 percent owner
21517582
94.5068%
$1.2240
STRATTAN CE RICK
19877647
87.304%
$1.2225
ARMISTICE CAPITAL, LLC10 percent owner
15795769
69.3761%
$1.22019
Farnan Joseph J Jrdirector
1340000
5.8854%
$1.2220
FINE N SCOTTChief Executive Officer
444402
1.9518%
$1.22170<0.0001%
Ostronic Francis Patrickdirector
222371
0.9767%
$1.22320<0.0001%
Sieger Markusdirector
161051
0.7073%
$1.22130+30.24%
SHANAHAN WILLIAM Sdirector
63677
0.2797%
$1.22110+74.7%
TATE JEFFREYChief Operating Officer
62101
0.2728%
$1.2260+14.85%
Toig Randall M.director
34078
0.1497%
$1.2250+74.7%
Hrynkow Sharon HemondChief Scientific Officer
19350
0.085%
$1.2260<0.0001%
Fine Joshua MChief Financial Officer
16900
0.0742%
$1.2230<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
EPIQ Capital Group$1.19M2.98853,815New+$1.19M0.48
Founders Fund V Management Llc$668,184.001.68480,7080%+$00.32
The Vanguard Group$551,355.001.39396,658+11.66%+$57,594.69<0.0001
Geode Capital Management$222,109.000.56159,749+5.04%+$10,666.86<0.0001
Founders Fund Vi Management Llc$152,932.000.38110,0230%+$02.02
State Street$54,947.000.1439,530+0.01%+$6.95<0.0001
BlackRock$51,605.000.1337,126-23.36%-$15,731.98<0.0001
Northern Trust$30,220.000.0821,741+24.57%+$5,960.32<0.0001
Renaissance Technologies$30,000.000.0821,756New+$30,000.00<0.0001
Wealth Enhancement Advisory Services LLC$28,356.000.0720,400+10.19%+$2,622.93<0.0001
Tower Research Capital$9,149.000.026,582+12.11%+$988.29<0.0001
UBS$6,711.000.024,828New+$6,711.00<0.0001
Wells Fargo$6,345.000.024,565+91.32%+$3,028.64<0.0001
Morgan Stanley$1,441.00<0.011,037+151.09%+$867.10<0.0001
Royal Bank of Canada$1,000.00<0.017460%+$0<0.0001
JPMorgan Chase$213.00<0.01153+750%+$187.94<0.0001
Qube Research & Technologies$29.00<0.0121-82.64%-$138.09<0.0001
Advisor Group Holdings Inc$93.00<0.0167-88.83%-$739.84<0.0001
Steward Partners Investment Advisory LLC$125.00<0.01900%+$0<0.0001
Bank of America$38.00<0.0127+92.86%+$18.30<0.0001